Masahiko Isa-Nishitani
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation.
Journal: Science immunology
Published: August 07, 2026
A genotype-first approach reveals the molecular basis of pyrin inflammasome activation.
Journal: Science immunology
Published: August 07, 2026
Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.
Journal: NPJ precision oncology
Published: February 14, 2026
Dried blood spot proteome identifies subclinical interferon signature in neonates with type I interferonopathy.
Journal: The Journal of allergy and clinical immunology
Published: September 19, 2024
A Non-targeted Proteomics Newborn Screening Platform for Inborn Errors of Immunity.
Journal: Journal of clinical immunology
Published: April 20, 2024
Autoinflammatory patients with Golgi-trapped CDC42 exhibit intracellular trafficking defects leading to STING hyperactivation and ER stress.
Journal: Nature communications
Published: January 26, 2024
Case Report: A Pediatric Case of Familial Mediterranean Fever Concurrent With Autoimmune Hepatitis.
Journal: Frontiers in immunology
Published: April 11, 2022
Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity.
Journal: The Journal of experimental medicine
Published: November 09, 2021
Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation.
Journal: The Journal of experimental medicine
Published: September 06, 2021
Pyoderma gangrenosum associated with chronic recurrent multifocal osteomyelitis as a possible paradoxical reaction to anti-tumor necrosis factor-α therapy.
Journal: The Journal of dermatology
Published: June 10, 2020
Last Updated: 09/26/2026